What types of bacteria are commonly used as vectors?

Common bacterial vectors include attenuated strains of Salmonella, Listeria, Mycobacterium bovis BCG, and various probiotic bacteria.

What advantages do bacterial vectors offer for vaccine delivery?

Bacterial vectors can induce strong mucosal immunity, offer inherent adjuvanticity, and allow for oral administration, making them highly effective for certain diseases.

Can bacterial vector vaccines be customized for specific pathogens?

Yes, bacterial vector vaccines can be precisely designed to deliver antigens from a wide range of pathogens, including bacteria, viruses, and parasites.

What are the key steps in bacterial vector vaccine design?

Key steps involve selecting the appropriate bacterial strain, engineering it to express the desired antigen, and optimizing the delivery system for optimal immune stimulation.

What role does Creative Biolabs play in bacterial vector vaccine development?

Creative Biolabs offers comprehensive services for customized bacterial vector vaccine design, engineering, and preclinical evaluation, leveraging various bacterial platforms and antigen delivery strategies.

Bacterial Vector Vaccine Solution

Creative Biolabs offers comprehensive preclinical services for bacterial vaccine development. Leveraging our expertise in bacterial vector vaccine design, we engineer live bacterial cells, including attenuated strains and probiotics, to effectively deliver recombinant antigens. Our services encompass various antigen delivery strategies such as bacterial surface display and secretion systems. These advanced platforms facilitate potent host immune responses, providing a cost-effective and innovative solution for new vaccine research and preclinical evaluation.

Talk To Our Vaccine Experts View Services Available products

End-to-end bacterial vector vaccine solutions

What is a bacterial vector vaccine?

A bacterial vector vaccine utilizes live bacterial cells as a delivery system to introduce specific recombinant antigens into a host, stimulating a robust immune response. These engineered living bacteria, which can include attenuated strains or probiotics, are designed to express heterologous proteins from pathogens. Once administered, the bacterial vectors present these antigens to the immune system, mimicking a natural infection and inducing both humoral and cellular immunity. This approach offers advantages such as controlled infectious power, non-integrative properties, and potent immune stimulation, often at relatively low manufacturing costs. Creative Biolabs employs various strategies like bacterial surface display and secretion systems to achieve effective antigen delivery.

Comprehensive Bacterial Vector Vaccine Preclinical Solution

Creative Biolabs specializes in Bacterial Vector Vaccine services, offering a unique and effective alternative in vaccine development. While the market frequently highlights viral vector approaches, we focus on engineering live bacterial cells, including attenuated bacteria and probiotics, to deliver recombinant antigens. Our comprehensive services encompass various strategies like bacterial surface display and secretion systems, enabling potent immune stimulation. We leverage diverse bacterial species to develop innovative, cost-effective vaccine candidates for preclinical research, distinguishing our focused expertise in this field.

Comprehensive Service Portfolio

Vaccine Design Adjuvant selection Analysis & ValidationFormulation Development Preclinical Testing

Customized Bacterial Vector Vaccine Design

Customized Bacterial Vector Selection: Tailored attenuation of pathogenic strains (e.g., Salmonella, Listeria, E. coli) for optimal safety and immunogenicity.
Antigen Engineering & Integration: Precision cloning of target antigens (toxins, surface proteins) with optimized expression cassettes for enhanced immunogenicity.
Vector Optimization: Genetic modifications (e.g., promoter tuning, secretion signals) to maximize antigen presentation and immune activation.
Synthetic Biology Solutions: De novo design of novel bacterial vectors using advanced genome editing and synthetic biology tools.

Adjuvant Development & Optimization

Adjuvant Screening & Evaluation: High-throughput screening of immune-boosting adjuvants (e.g., TLR agonists, bacterial membrane proteins) for optimal compatibility with bacterial vectors (e.g., Salmonella, Listeria).
Adjuvant-Vector Synergy Optimization: Genetic and formulation-based tuning of adjuvants (e.g., flagellin, LPS derivatives) to enhance vector immunogenicity while maintaining safety.
Mucosal Adjuvant Development: Specialized adjuvants (e.g., M-cell targeting ligands, cytokine co-expression) for oral/nasal bacterial vector vaccines to enhance mucosal immunity.

Analytical Development & Preclinical Validation

Comprehensive Analytical Development: Advanced characterization of bacterial vector vaccines, including purity, potency, and stability testing using HPLC, SDS-PAGE, and dynamic light scattering (DLS) to ensure product consistency.
Immunogenicity Profiling: In-depth evaluation of humoral and cellular immune responses via ELISA, ELISpot, and flow cytometry to assess vaccine efficacy in preclinical models.
Safety & Toxicology Studies: GLP-compliant acute/repeat-dose toxicity studies in rodents and non-rodents to validate vaccine safety profiles.

Formulation & Process Development

Optimized Formulation Development: Customized bacterial vector vaccine formulations (e.g., Salmonella, Listeria) with tailored adjuvants (TLR agonists, bacterial membrane proteins) to enhance stability and immunogenicity.
Scalable Fermentation & Purification: High-density bacterial fermentation and downstream process optimization (ultrafiltration, chromatography) for GMP-compliant manufacturing.
Mucosal Vaccine Formulation: Specialized formulations (e.g., enteric coatings, nanoparticle encapsulation) for oral/nasal delivery to enhance mucosal immune responses.

Preclinical Testing

Challenge Models & Protection Studies: Controlled pathogen exposure trials in animal models (e.g., Salmonella, Listeria) to assess vaccine-induced protection against target infections.
Biomarker & Pharmacodynamics Analysis: Quantification of immune correlates (e.g., cytokine levels, T-cell activation) to optimize dosing and formulation strategies.

Featured Bacterial vector Vaccine Design Services

Lactobacillus based Vaccine-Vector Design

Capable of eliciting strong systemic and mucosal immune responses.
Genetically modifiable with good acceptance and stability.
Relatively low cost and high safety level.

Lactococcus lactis based Vaccine-Vector Design

Can resist the stomach acidic environment and survive in the gastrointestinal tract.
Lacks lipopolysaccharides in its cell wall, eliminating endotoxin shock risk.

Salmonella based Vaccine-Vector Design

The type 3 secretion system can directly secrete antigens into host cell cytosol.
Engineered to withstand the challenges of the gastrointestinal tract, like low pH.

Bacillus subtilis based Vaccine-Vector Design

Can effectively trigger an immune response in the body.
Has been used to develop oral vaccines for diseases like rabies.

Pseudomonas aeruginosa based Vaccine-Vector Design

Engineered for targeted antigen presentation with strict safety attenuation.
Induces robust cellular immune responses via specific mechanisms.

Shigella based Vaccine-Vector Design

Attenuated to deliver antigens to mucosal immune systems.
Enables controlled intracellular antigen presentation for potent responses.

Vibrio cholerae based Vaccine-Vector Design

Modified to display foreign antigens while retaining key immunogenic traits.
Mimics natural infection to boost vaccine immunogenicity.

Vibrio anguillarum based Vaccine-Vector Design

Elicits immune responses in aquatic animal systems.
Adapted for antigen presentation in target aquatic species.

Streptococcus based Vaccine-Vector Design

Engineered to present specific antigens for targeted immunity.
Colonizes mucosal surfaces to stimulate local immune responses.

Bordetella pertussis based Vaccine-Vector Design

Leverages natural interaction to induce strong immune responses.
Targets respiratory mucosa for protection against respiratory pathogens.

Yersinia enterocolitica based Vaccine-Vector Design

Triggers strong gut mucosal immunity effectively.
Enhanced antigen presentation for better immunogenicity.

Listeria monocytogenes based Vaccine-Vector Design

Invades host cells to deliver antigens directly into cytosol.
Suitable for developing vaccines against intracellular pathogens.

Mycobacterium smegmatis based Vaccine-Vector Design

Stimulates long-lasting immune responses.
Promotes memory immune cell development for long-term protection.

Mycobacterium bovis BCG based Vaccine-Vector Design

Stimulates both cellular and humoral immunity.
Persists long-term to maintain immunological memory.

Corynebacterium pseudotuberculosis based Vaccine-Vector Design

Targets specific tissues based on natural tropism.
Enhanced antigen immunogenicity for effective protection.

How Dose Bacterial Vector Vaccine Solution Work?

1. Antigen Design and Optimization

Pathogen genome analysis based on high-throughput sequencing platform
AI online platform predicts highly immunogenic epitopes
Optimizing and modifying candidate antigens to enhance their immunogenicity and stability.

2. Immunization Strategy Development

Outer Membrane Vesicle Platform induces antigen expression
Optimization of adjuvant compatibility (aluminum adjuvant, TLR agonist)
Delivery system customization (nanoparticles/liposomes)

3. Immunogenicity Assessment

Humoral immunity testing (IgG/IgA subtypes, neutralizing antibody titers)
Cellular immune assay (Th1/Th2/Th17 response profile)
ADCP/ADCD functional verification

4. Animal Model Verification

Customized challenge model (mouse/guinea pig/rabbit)
Protection effectiveness evaluation (LD50, bacterial load monitoring)
Safety assessment (local/systemic toxicity)

5. Report

Screening analysis reports
Test data reports
Project design document

Online Inquiry

Getting Started with Your Vaccine Project

Professional Vaccine Solution Platform

Antigen Prediction System Platform

Our Antigen Prediction System Platform integrates advanced bioinformatics and computational biology tools to identify and prioritize immunogenic antigens. Leveraging cutting-edge algorithms, we analyze pathogen genomes or cancer markers to predict key epitopes that elicit robust immune responses. This platform enables the rational design of vaccines by pinpointing high-potency antigens, significantly accelerating the development process for bacterial, viral, fungal, parasitic, and cancer-targeted vaccines. By combining traditional immunology with state-of-the-art predictive modeling, we ensure optimal antigen selection for maximum immunogenicity and efficacy.

Protein Expression Platform

The Protein Expression Platform at Creative Biolabs offers versatile solutions for producing recombinant antigens using multiple expression systems. We specialize in optimizing bacterial (e.g., E. coli), yeast, insect, and mammalian cell systems to meet diverse production needs. Our expertise in genetic engineering allows us to tailor expression vectors, culture conditions, and purification protocols for high-yield, biologically active proteins. Whether for preclinical research or large-scale manufacturing, our platform ensures consistent production of immunogenic proteins, supporting the development of vaccines with enhanced stability and immunogenicity. We seamlessly integrate expression technologies with downstream analytical and formulation services to streamline the vaccine development pipeline.

Modular Delivery System Platform

Our Modular Delivery System Platform is designed to enhance vaccine potency and delivery efficiency through customizable, multi-component formulations. Focused on optimizing delivery mechanisms, we develop lipid-based nanoparticles, viral-like particles (VLPs), and other nano-carriers to protect antigens, improve cellular uptake, and modulate immune responses. The modular design allows for precise integration of adjuvants, targeting ligands, and protective matrices, enabling tailor-made systems for various vaccine types—from prophylactic to therapeutic.

Why Choose Our Bacterial Vector Vaccine Services?

High Safety Profile

Our bacterial vector vaccines are developed with an unwavering focus on safety. We employ rigorously attenuated or inherently non-pathogenic bacterial strains as vectors, which have undergone extensive preclinical testing to ensure they cannot revert to virulent forms.

Efficient Immune Response Induction

Capable of triggering both mucosal and systemic immune responses, ensuring comprehensive protection against pathogens.

Custom - tailored Solutions

Our team works closely with clients to understand their unique pathogen targets, research goals, and application scenarios, then engineers vectors with precise antigen expression and delivery capabilities to meet those specific requirements.

Cost-effective and Scalable

With an easy-to-culture vector system, our solutions are cost-effective and highly scalable for large-scale production.

Available Products

Antigen Products Antibody Products Adjuvant Products Delivery System related Products

Array Kits Cell Culture Medium Proudcts

FAQs About Our Bacterial Vector Vaccine Solution

What types of bacteria are commonly used as vectors?

Common bacterial vectors include attenuated strains of Salmonella, Listeria, Mycobacterium bovis BCG, and various probiotic bacteria.
What advantages do bacterial vectors offer for vaccine delivery?

Bacterial vectors can induce strong mucosal immunity, offer inherent adjuvanticity, and allow for oral administration, making them highly effective for certain diseases.
Can bacterial vector vaccines be customized for specific pathogens?

Yes, bacterial vector vaccines can be precisely designed to deliver antigens from a wide range of pathogens, including bacteria, viruses, and parasites.
What are the key steps in bacterial vector vaccine design?

Key steps involve selecting the appropriate bacterial strain, engineering it to express the desired antigen, and optimizing the delivery system for optimal immune stimulation.
What role does Creative Biolabs play in bacterial vector vaccine development?

Creative Biolabs offers comprehensive services for customized bacterial vector vaccine design, engineering, and preclinical evaluation, leveraging various bacterial platforms and antigen delivery strategies.

Related Resources

Download Resources

Literature Center

Podcast